While all providers asked their patients about their use of tobacco, alcohol and illegal drugs, discussion was more thorough concerning the adverse effects of smoking and related resources for smoking cessation compared to other risk factors. Provider responses to alcohol or drug disclosures included only general statements regarding effects on pregnancy, such as We find this is bad for babies, said Dr. Chang, who also is an MWRI investigator. Few alcohol or drug discussions assessed whether the patient had concerns regarding continued use during the pregnancy, or strategies for behavioral change.
Providers who talked about alcohol and drug use tended to refer their substance-using patients to genetics specialists for further evaluation rather than confront the issue more directly. In follow-up interviews, however, patients said they expected to be asked about substance use, and voiced a need for more information on possible fetal effects.
In addition to Dr. Chang, other authors include Diane Dado, M.S.W., Magee-Womens Hospital of UPMC; Robert Arnold, M.D., University of Pittsburgh School of Medicine; and Richard Frankel, Ph.D., Indiana University School of Medicine.
This is Abstract No. 407. Dr. Chang is discussing this work as part of a presentation, Health Services Research in Womens Health: The Science of Caring for Patients, at 1:30 p.m., PDT, March 27. Dr. Chang also is presenting a poster at 9 a.m., PDT, March 28.
Elevated markers of maternal cardiovascular risk persist even 10 years after preterm birth
|Contact: Michele Baum|
University of Pittsburgh Schools of the Health Sciences